This is one of the most significant things that has happened in psychiatry in the last 40 years if previous research results prove to be correct in a clinical trial, the researcher says.

In Sweden The Karolinska Institut will start this fall research, which aims to investigate the effect of psilocybin in the treatment of depression.

Psilocybin is a psychedelic substance that causes aberrant, dreamy states of consciousness. It occurs naturally in some fungi. This is the first clinical trial of psychedelics in Sweden.

.

Read more:
Neuroscience Sweden is starting to study psychedels in the treatment of depression: the results could be revolutionary - Pledge Times